Eukaryotic cell-free protein synthesis: Chassis diversification, system engineering, and emerging applications
Synthetic and Systems Biotechnology · 2026-12 · 14 · 280-309
DOI: 10.1016/j.synbio.2026.04.022 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Synthetic and Systems Biotechnology, 2026-12. Verfasst von Shengxin Tong und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Shenyang Normal University, Shenyang, 110034, Liaoning, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 334 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The eukaryotic cell-free protein synthesis (CFPS) system, endowed with intrinsic post-translational modification capabilities and a complex molecular chaperone network, efficiently synthesizes functional proteins with correct conformation and biological activity. This effectively compensates for the structural limitations of prokaryotic systems in expressing complex eukaryotic proteins. This paper aims to comprehensively review and analyze the latest advances in the field of eukaryotic CFPS from a systems engineering perspective. The paper delves into the diversification of host chassis, rational design of core reaction components, and the pivotal role of novel biomaterial integration and high-throughput reaction equipment development in system reconfiguration. At the application level, it summarizes the platform's latest achievements, including elucidation of fundamental mechanisms, complex protein engineering, and metabolic synthesis. It particularly highlights its potential in emerging areas such as the construction of artificial cells, the development of bioelectronic interfaces, and the design of microarray chips. Furthermore, addressing the current standardization and cost bottlenecks hindering industrialization, this paper proposes a solution strategy based on artificial intelligence and synthetic biology tools, aligning with the shift from empirical trial-and-error to rational design paradigms. By integrating the current technological landscape with emerging trends, this review aims to provide theoretical references and practical guidance for constructing an economical, high-throughput eukaryotic cell-free biomanufacturing platform.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Life Sciences, Shenyang Normal University, Shenyang, 110034, Liaoning, China.
- Department of Chemical Engineering, Tsinghua University, Beijing, 100084, China.
- State Key Laboratory of Green Biomanufacturing, Department of Chemical Engineering, Tsinghua University, Beijing, 100084, China.
- Key Laboratory of Industrial Biocatalysis, Ministry of Education, Department of Chemical Engineering, Tsinghua University, Beijing, 100084, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Tong, S., Wang, Y., Wang, X., Jin, X., Tan, D., Wang, Z., & Lu, Y. (2026). Eukaryotic cell-free protein synthesis: Chassis diversification, system engineering, and emerging applications. Synthetic and Systems Biotechnology, 14, 280-309. https://doi.org/10.1016/j.synbio.2026.04.022
Vancouver
Tong S, Wang Y, Wang X, Jin X, Tan D, Wang Z, et al. Eukaryotic cell-free protein synthesis: Chassis diversification, system engineering, and emerging applications. Synthetic and Systems Biotechnology. 2026;14:280-309. doi:10.1016/j.synbio.2026.04.022
BibTeX
@article{Tong2026,
author = {Tong, Shengxin and Wang, Yiming and Wang, Xin and Jin, Xiaowen and Tan, Duoduo and Wang, Ze and Lu, Yuan},
title = {Eukaryotic cell-free protein synthesis: Chassis diversification, system engineering, and emerging applications},
journal = {Synthetic and Systems Biotechnology},
year = {2026},
volume = {14},
pages = {280--309},
doi = {10.1016/j.synbio.2026.04.022}
}
EUVIMED